-
ML385: Practical NRF2 Inhibition Workflows
2026-09-05
ML385 provides a practical pharmacological handle for testing NRF2-dependent antioxidant signaling, therapeutic resistance, and redox-sensitive phenotypes. This workflow connects non-small cell lung cancer research with emerging NRF2 studies in inflammation and osteolysis while emphasizing controls, target engagement, and troubleshooting.
-
VE-821 ATR Kinase Inhibitor Workflow Guide
2026-09-04
VE-821 enables selective ATR checkpoint inhibition for DNA damage response studies, radiosensitization assays, and chemotherapy sensitization workflows. This guide connects practical assay design with the DNMT1-centered HBoV1 findings while clearly separating established product applications from exploratory cross-domain hypotheses.
-
Streptavidin-HyperFluor 647: Assay Design
2026-09-04
Streptavidin-HyperFluor 647 supports sensitive red-fluorescent detection of biotinylated targets. This article presents a readout-first framework for choosing it across microscopy, flow cytometry, FRET, and proximity-labeling workflows.
-
Machine Learning Prediction of mRNA Vaccine LNPs
2026-09-04
The reference study developed a LightGBM model that predicted lipid nanoparticle formulations for mRNA vaccines with an R² above 0.87 from 325 formulation records. By combining machine learning, mouse validation, and molecular dynamics, it showed how computational screening can prioritize ionizable lipids and formulation conditions while also identifying structural features relevant to performance.
-
GPNMB Model Predicts ESCC Immunotherapy Response
2026-09-03
This reference study links circulating soluble GPNMB to a CAF–epithelial niche, SOX2 activation, CD8+ T-cell exhaustion, and resistance to PD-1 blockade in esophageal squamous cell carcinoma. Its multimodal model combines plasma, spatial, and clinicopathologic information to improve response and survival prediction, while offering a mechanistic framework for biomarker-guided immunotherapy research.
-
Vasopressin Analogues: Structure, Signaling, and Translation
2026-09-02
Glavaš and colleagues review how vasopressin structure, receptor signaling, and peptide engineering create analogues with distinct antidiuretic, vasoconstrictor, and therapeutic profiles. The article is particularly useful for interpreting lypressin, desmopressin, and terlipressin across endocrine, cardiovascular, and emerging antiviral research while distinguishing established applications from preliminary hypotheses.
-
SM-102 LNP Workflow for mRNA Delivery
2026-09-02
SM-102 is a practical ionizable-lipid benchmark for building and comparing lipid nanoparticles in mRNA vaccine development. This workflow combines solvent handling, N/P-ratio screening, assay controls, and machine-learning-informed formulation choices while keeping experimental limitations explicit.
-
Multianimal MRI in Pancreatic Cancer Mouse Models
2026-09-01
Kempinska and colleagues present a four-chamber MRI workflow that enables high-resolution imaging of multiple KPC mice during one acquisition, addressing the time and cost barriers of serial tumor monitoring. The protocol also provides a practical framework for linking quantitative tumor measurements with gemcitabine treatment-response studies in pancreatic ductal adenocarcinoma models.
-
Fiber Density Reconstructs Annulus Fibrosus Heterogeneity
2026-09-01
The reference study shows that fiber density, independent of scaffold composition, can direct annulus fibrosus cell phenotypes through distinct mechanotransduction programs. Its findings provide a biomaterial design rationale for generating collagen type I- and type II-rich regions, while identifying Piezo1-associated calcium signaling as a candidate mechanism for further investigation.
-
JHU-083: A Compartment-Aware Assay Strategy
2026-08-31
JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor for studying glutaminase activity in cerebral CD11b cells and glutamate-driven pathology. This guide presents a compartment-aware assay framework that separates validated neuroinflammatory applications from exploratory redox research.
-
Estrogen Receptor–Autophagy Axis in Perimenopause
2026-08-31
The reference study integrates NHANES analysis, a perimenopausal mouse model, network pharmacology, and inhibitor-based validation to examine how declining estradiol affects the heart, aorta, and kidneys. Its central contribution is linking receptor-dependent estrogen signaling to autophagy as a shared mechanism of multi-organ protection, while also highlighting the limits of translating observational associations into hormone-therapy recommendations.
-
Dehydroabietic Acid: Dual PPAR-α/γ Agonist
2026-08-30
Dehydroabietic acid is a resin-derived small molecule described as a dual PPAR-α/γ agonist for lipid metabolism regulation and insulin sensitivity research. The N2850 product offers ≥98% purity, organic-solvent solubility, and defined cold-storage guidance, while current triacetin evidence provides metabolic context rather than direct evidence for dehydroabietic acid.
-
2-APB: Time-Resolved ER Calcium Assay Design
2026-08-29
2-APB (2-aminoethoxydiphenyl borate) is a versatile perturbation tool for dissecting ER calcium release, calcium oscillations, and cell-fate transitions. This guide translates starvation-induced ER-Ca2+-calpain findings into better-timed, better-controlled assays for SOCE, oxidative injury, and apoptosis research.
-
OSMI-1 Workflow for O-GlcNAc Research
2026-08-28
OSMI-1 provides a cell-permeable way to reduce OGT activity and interrogate how protein O-GlcNAc modification influences trophoblast stress, iron handling, and ferroptosis. This practical guide combines target-engagement assays, dose and time optimization, and controls that help distinguish pathway biology from compound-associated cytotoxicity.
-
ML-Guided mRNA LNPs Reprogram Microglia
2026-08-28
Rafiei, Shojaei, and Chau combined supervised machine learning with lipid nanoparticle screening to identify an mRNA carrier capable of shifting hyperactivated microglia toward a less inflammatory state. The study shows that formulation composition, hyaluronic acid modification, cell state, transfection efficiency, and phenotype can be analyzed together, while also demonstrating the limits of model transfer across microglial subtypes.